{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T15:31:51Z","timestamp":1793460711420,"version":"4.5.0"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"46","license":[{"start":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T00:00:00Z","timestamp":1792108800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T00:00:00Z","timestamp":1792108800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Oncogene"],"published-print":{"date-parts":[[2026,12,2]]},"DOI":"10.1038\/s41388-026-04017-y","type":"journal-article","created":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T04:09:06Z","timestamp":1792123746000},"page":"4990-5001","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Dynamic remodeling of the KRAS interactome by direct RAS inhibitors with distinct mechanism of action reveals convergent responses"],"prefix":"10.1038","volume":"45","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8128-8752","authenticated-orcid":false,"given":"Yang","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tingyu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles Y.","family":"Cho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xianzhong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8080-3107","authenticated-orcid":false,"given":"Ansgar","family":"Brock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Doug","family":"Quackenbush","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaisheng","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederick","family":"Lo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8751-9707","authenticated-orcid":false,"given":"Cyril H.","family":"Benes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6079-3722","authenticated-orcid":false,"given":"Jacob R.","family":"Haling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,16]]},"reference":[{"key":"4017_CR1","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1038\/s41573-020-0068-6","volume":"19","author":"AR Moore","year":"2020","unstructured":"Moore AR, Rosenberg SC, McCormick F, Malek S. RAS-targeted therapies: is the undruggable drugged? Nat Rev Drug Discov. 2020;19:533\u201352.","journal-title":"Nat Rev Drug Discov"},{"key":"4017_CR2","doi-asserted-by":"crossref","unstructured":"Terrell EM, Morrison DK Ras-mediated activation of the Raf family kinases. Cold Spring Harb Perspect Med. 2019 Jan 1;9.","DOI":"10.1101\/cshperspect.a033746"},{"key":"4017_CR3","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1038\/s43018-021-00184-x","volume":"2","author":"S Mukhopadhyay","year":"2021","unstructured":"Mukhopadhyay S, Vander Heiden MG, McCormick F. The metabolic landscape of RAS-driven cancers from biology to therapy. Nat Cancer. 2021;2:271\u201383.","journal-title":"Nat Cancer"},{"key":"4017_CR4","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1016\/j.molcel.2018.12.001","volume":"73","author":"JR Kovalski","year":"2019","unstructured":"Kovalski JR, Bhaduri A, Zehnder AM, Neela PH, Che Y, Wozniak GG, et al. The functional proximal proteome of oncogenic Ras includes mTORC2. Mol Cell. 2019;73:830\u2013844.e12.","journal-title":"Mol Cell"},{"key":"4017_CR5","doi-asserted-by":"crossref","unstructured":"Huang L, Guo Z, Wang F, Fu L. KRAS mutation: from undruggable to druggable in cancer. 6, Signal Transduction and Targeted Therapy. Springer Nature; 2021.","DOI":"10.1038\/s41392-021-00780-4"},{"key":"4017_CR6","doi-asserted-by":"crossref","unstructured":"Kwan AK, Piazza GA, Keeton AB, Leite CA. The path to the clinic: a comprehensive review on direct KRASG12C inhibitors. Vol. 41, Journal of Experimental and Clinical Cancer Research. BioMed Central Ltd; 2022.","DOI":"10.1186\/s13046-021-02225-w"},{"key":"4017_CR7","doi-asserted-by":"publisher","first-page":"2382","DOI":"10.1056\/NEJMoa2105281","volume":"384","author":"MM Awad","year":"2021","unstructured":"Awad MM, Liu S, Rybkin II, Arbour KC, Dilly J, Zhu VW, et al. Acquired resistance to KRAS G12C inhibition in cancer. N Engl J Med. 2021;384:2382\u201393.","journal-title":"N Engl J Med"},{"key":"4017_CR8","first-page":"1171","volume":"362","author":"JW Bigenzahn","year":"2018","unstructured":"Bigenzahn JW, Collu GM, Kartnig F, Pieraks M, Vladimer GI, Heinz LX, et al. LZTR1 is a regulator of RAS ubiquitination and signaling. Science (1979). 2018;362:1171\u20137.","journal-title":"Science (1979)"},{"key":"4017_CR9","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-05692-6","volume":"9","author":"H Adhikari","year":"2018","unstructured":"Adhikari H, Counter CM. Interrogating the protein interactomes of RAS isoforms identifies PIP5K1A as a KRAS-specific vulnerability. Nat Commun. 2018;9:3646.","journal-title":"Nat Commun"},{"key":"4017_CR10","doi-asserted-by":"publisher","first-page":"1889","DOI":"10.1016\/j.celrep.2018.01.051","volume":"22","author":"TL Yuan","year":"2018","unstructured":"Yuan TL, Amzallag A, Bagni R, Yi M, Afghani S, Burgan W, et al. Differential effector engagement by oncogenic KRAS. Cell Rep. 2018;22:1889\u2013902.","journal-title":"Cell Rep"},{"key":"4017_CR11","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.3390\/cells9051070","volume":"9","author":"DG May","year":"2020","unstructured":"May DG, Scott KL, Campos AR, Roux KJ. Comparative application of BioID and TurboID for protein-proximity biotinylation. Cells. 2020;9:1070.","journal-title":"Cells"},{"key":"4017_CR12","doi-asserted-by":"publisher","first-page":"2503","DOI":"10.1002\/pmic.201600123","volume":"16","author":"R Varnait\u0117","year":"2016","unstructured":"Varnait\u0117 R, MacNeill SA. Meet the neighbors: mMapping local protein interactomes by proximity-dependent labeling with BioID. Proteomics. 2016;16:2503\u201318.","journal-title":"Proteomics"},{"key":"4017_CR13","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1038\/nbt.4201","volume":"36","author":"TC Branon","year":"2018","unstructured":"Branon TC, Bosch JA, Sanchez AD, Udeshi ND, Svinkina T, Carr SA, et al. Efficient proximity labeling in living cells and organisms with TurboID. Nat Biotechnol. 2018;36:880\u201398.","journal-title":"Nat Biotechnol"},{"key":"4017_CR14","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1038\/s41592-020-01018-x","volume":"18","author":"C Stringer","year":"2021","unstructured":"Stringer C, Wang T, Michaelos M, Pachitariu M. Cellpose: a generalist algorithm for cellular segmentation. Nat Methods. 2021;18:100\u20136.","journal-title":"Nat Methods"},{"key":"4017_CR15","doi-asserted-by":"publisher","first-page":"1226","DOI":"10.1038\/s41592-019-0582-9","volume":"16","author":"S Berg","year":"2019","unstructured":"Berg S, Kutra D, Kroeger T, Straehle CN, Kausler BX, Haubold C, et al. ilastik: interactive machine learning for (bio)image analysis. Nat Methods. 2019;16:1226\u201332.","journal-title":"Nat Methods"},{"key":"4017_CR16","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1002\/cyto.a.23249","volume":"93","author":"CM Svensson","year":"2018","unstructured":"Svensson CM, Medyukhina A, Belyaev I, Al-Zaben N, Figge MT. Untangling cell tracks: Quantifying cell migration by time lapse image data analysis. Cytom Part A Wiley-Liss Inc. 2018;93:357\u201370.","journal-title":"Cytom Part A Wiley-Liss Inc"},{"key":"4017_CR17","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1002\/pro.3978","volume":"30","author":"R Oughtred","year":"2021","unstructured":"Oughtred R, Rust J, Chang C, Breitkreutz BJ, Stark C, Willems A, et al. The BioGRID database: A comprehensive biomedical resource of curated protein, genetic, and chemical interactions. Protein Sci. 2021;30:187\u2013200.","journal-title":"Protein Sci"},{"key":"4017_CR18","doi-asserted-by":"publisher","first-page":"e2300088","DOI":"10.1002\/bies.202300088","volume":"45","author":"MJ Smith","year":"2023","unstructured":"Smith MJ. Defining bone fide effectors of RAS GTPases. BioEssays. 2023;45:e2300088.","journal-title":"BioEssays"},{"key":"4017_CR19","doi-asserted-by":"publisher","first-page":"2008","DOI":"10.1242\/jcs.024620","volume":"121","author":"N Kanzaki","year":"2008","unstructured":"Kanzaki N, Ogita H, Komura H, Ozaki M, Sakamoto Y, Majima T, et al. Involvement of the nectin-afadin complex in PDGF-induced cell survival. J Cell Sci. 2008;121:2008\u201317.","journal-title":"J Cell Sci"},{"key":"4017_CR20","doi-asserted-by":"crossref","unstructured":"Ikeda W, Nakanishi H, Miyoshi J, Mandai K, Ishizaki H, Tanaka M, et al. Afadin: A Key Molecule Essential for Structural Organization of Cell-Cell Junctions of Polarized Epithelia during Embryogenesis [Internet]. Vol. 146, J Cell Biol. 1999. Available from: http:\/\/www.jcb.org.","DOI":"10.1083\/jcb.146.5.1117"},{"key":"4017_CR21","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms8184","volume":"6","author":"Y Xu","year":"2015","unstructured":"Xu Y, Chang R, Peng Z, Wang Y, Ji W, Guo J, et al. Loss of polarity protein AF6 promotes pancreatic cancer metastasis by inducing Snail expression. Nat Commun. 2015;6:7184.","journal-title":"Nat Commun"},{"key":"4017_CR22","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-017-01326-5","volume":"8","author":"MJ Smith","year":"2017","unstructured":"Smith MJ, Ottoni E, Ishiyama N, Goudreault M, Haman A, Meyer C, et al. Evolution of AF6-RAS association and its implications in mixed-lineage leukemia. Nat Commun. 2017;8:1099.","journal-title":"Nat Commun"},{"key":"4017_CR23","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1074\/jbc.271.2.607","volume":"271","author":"M Kuriyama","year":"1996","unstructured":"Kuriyama M, Harada N, Kuroda S, Yamamoto T, Nakafuku M, Iwamatsu A, et al. Identification of AF-6 and Canoe as putative targets for Ras. J Biol Chem. 1996;271:607\u201310.","journal-title":"J Biol Chem"},{"key":"4017_CR24","doi-asserted-by":"publisher","unstructured":"Damianou A, Liang Z, Lassen F, Vere G, Hester S, Charles PD, et al. Interplay Between KRAS and LZTR1 Protein Turnover, Controlled by CUL3\/LZTR1 E3 Ubiquitin Ligase, is Disrupted by KRAS Mutations. Available from: https:\/\/doi.org\/10.1101\/2021.11.23.469679.","DOI":"10.1101\/2021.11.23.469679"},{"key":"4017_CR25","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-32335-8","volume":"13","author":"M Goudreault","year":"2022","unstructured":"Goudreault M, Gagn\u00e9 V, Jo CH, Singh S, Killoran RC, Gingras AC, et al. Afadin couples RAS GTPases to the polarity rheostat Scribble. Nat Commun. 2022;13:4562.","journal-title":"Nat Commun"},{"key":"4017_CR26","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1158\/1541-7786.MCR-13-0398","volume":"12","author":"S Elloul","year":"2014","unstructured":"Elloul S, Kedrin D, Knoblauch NW, Beck AH, Toker A. The adherens junction protein Afadin is an AKT substrate that regulates breast cancer cell migration. Mol Cancer Res. 2014;12:464\u201376.","journal-title":"Mol Cancer Res"},{"key":"4017_CR27","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1038\/labinvest.2015.133","volume":"96","author":"H Tsurumi","year":"2016","unstructured":"Tsurumi H, Kurihara H, Miura K, Tanego A, Ohta Y, Igarashi T, et al. Afadin is localized at cell-cell contact sites in mesangial cells and regulates migratory polarity. Lab Investig. 2016;96:49\u201359.","journal-title":"Lab Investig"},{"key":"4017_CR28","first-page":"eaba5528","volume":"370","author":"HH Yu","year":"2020","unstructured":"Yu HH, Zallen JA. Abl and Canoe\/Afadin mediate mechanotransduction at tricellular junctions. Science (1979). 2020;370:eaba5528.","journal-title":"Science (1979)"},{"key":"4017_CR29","doi-asserted-by":"publisher","first-page":"e48216","DOI":"10.15252\/embr.201948216","volume":"20","author":"M Lundh","year":"2019","unstructured":"Lundh M, Petersen PS, Isidor MS, Kazoka-S\u00f8rensen DN, Pluci\u0144ska K, Shamsi F, et al. Afadin is a scaffold protein repressing insulin action via HDAC 6 in adipose tissue. EMBO Rep. 2019;20:e48216.","journal-title":"EMBO Rep"},{"key":"4017_CR30","doi-asserted-by":"publisher","first-page":"37815","DOI":"10.1074\/jbc.M707461200","volume":"282","author":"S Nakata","year":"2007","unstructured":"Nakata S, Fujita N, Kitagawa Y, Okamoto R, Ogita H, Takai Y. Regulation of platelet-derived growth factor receptor activation by afadin through SHP-2: Implications for cellular morphology. J Biol Chem. 2007;282:37815\u201325.","journal-title":"J Biol Chem"},{"key":"4017_CR31","first-page":"1893","volume":"15","author":"X Zhai","year":"2018","unstructured":"Zhai X, Li Y, Liang P, Li L, Zhou Y, Zhang W, et al. PI3K\/AKT\/Afadin signaling pathway contributes to pathological vascularization in glioblastomas. Oncol Lett. 2018;15:1893\u20139.","journal-title":"Oncol Lett"},{"key":"4017_CR32","doi-asserted-by":"publisher","first-page":"39379","DOI":"10.1074\/jbc.M206399200","volume":"277","author":"H Zhang","year":"2002","unstructured":"Zhang H, Zha X, Tan Y, Hornbeck PV, Mastrangelo AJ, Alessi DR, et al. Phosphoprotein analysis using antibodies broadly reactive against phosphorylated motifs. J Biol Chem. 2002;277:39379\u201387.","journal-title":"J Biol Chem"},{"key":"4017_CR33","doi-asserted-by":"publisher","DOI":"10.1126\/science.adk0850","volume":"384","author":"JE Klomp","year":"2024","unstructured":"Klomp JE, Diehl JN, Klomp JA, Edwards AC, Yang R, Morales AJ, et al. Determining the ERK-regulated phosphoproteome driving KRAS-mutant cancer. Science. 2024;384:eadk0850.","journal-title":"Science"},{"key":"4017_CR34","doi-asserted-by":"crossref","unstructured":"Moritz A, Li Y, Guo A, Vill\u00e9n J, Wang Y, Macneill J, et al. Akt-RSK-S6 Kinase Signaling Networks Activated by Oncogenic Receptor Tyrosine Kinases [Internet]. 2010. Available from: www.SCIENCESIGNALING.org.","DOI":"10.1126\/scisignal.2000998"},{"key":"4017_CR35","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.semcancer.2003.09.015","volume":"14","author":"PM Campbell","year":"2004","unstructured":"Campbell PM, Der CJ. Oncogenic Ras and its role in tumor cell invasion and metastasis. Semin Cancer Biol. 2004;14:105\u201314.","journal-title":"Semin Cancer Biol"},{"key":"4017_CR36","doi-asserted-by":"crossref","unstructured":"Huxham J, Tabari\u00e8s S, Siegel PM Afadin (AF6) in cancer progression: A multidomain scaffold protein with complex and contradictory roles. Vol. 43, BioEssays. John Wiley and Sons Inc; 2021.","DOI":"10.1002\/bies.202000221"},{"key":"4017_CR37","doi-asserted-by":"publisher","first-page":"3158","DOI":"10.1158\/0008-5472.CAN-23-3140","volume":"84","author":"S Liao","year":"2024","unstructured":"Liao S, Deng J, Deng M, Chen C, Han F, Ye K, et al. AFDN Deficiency Promotes Liver Tropism of Metastatic Colorectal Cancer. Cancer Res. 2024;84:3158\u201372.","journal-title":"Cancer Res"},{"key":"4017_CR38","doi-asserted-by":"publisher","unstructured":"Cheng DK, Oni TE, Thalappillil JS, Park Y, Ting HC, Alagesan B, et al. Oncogenic KRAS engages an RSK1\/NF1 pathway to inhibit wild-type RAS signaling in pancreatic cancer. Proc Natl Acad Sci [Internet]. 2021;118. Available from: https:\/\/doi.org\/10.1073\/pnas.2016904118.","DOI":"10.1073\/pnas.2016904118"},{"key":"4017_CR39","doi-asserted-by":"publisher","first-page":"115087","DOI":"10.1016\/j.celrep.2024.115087","volume":"44","author":"J Kochen Rossi","year":"2025","unstructured":"Kochen Rossi J, Nuevo-Tapioles C, O\u2019Keefe RA, Hunkeler M, Schmoker AM, Fissore-O\u2019Leary M, et al. The differential interactomes of the KRAS splice variants identify BIRC6 as a ubiquitin ligase for KRAS4A. Cell Rep. 2025;44:115087.","journal-title":"Cell Rep"},{"key":"4017_CR40","first-page":"477","volume":"14","author":"J Song","year":"2025","unstructured":"Song J, Wang B, Zou M, Zhou H, Ding Y, Ren W, et al. Mapping the Interactome of KRAS and Its G12C\/D\/V mutants by integrating TurboId proximity labeling with quantitative proteomics. Biol (Basel). 2025;14:477.","journal-title":"Biol (Basel)"},{"key":"4017_CR41","doi-asserted-by":"publisher","first-page":"3326","DOI":"10.3390\/cancers12113326","volume":"12","author":"B B\u00e9ganton","year":"2020","unstructured":"B\u00e9ganton B, Coyaud E, Laurent EMN, Mang\u00e9 A, Jacquemetton J, Le Romancer M, et al. Proximal protein interaction landscape of RAS paralogs. Cancers (Basel). 2020;12:3326.","journal-title":"Cancers (Basel)"},{"key":"4017_CR42","doi-asserted-by":"publisher","first-page":"3971","DOI":"10.1038\/s41596-020-0399-0","volume":"15","author":"KF Cho","year":"2020","unstructured":"Cho KF, Branon TC, Udeshi ND, Myers SA, Carr SA, Ting AY. Proximity labeling in mammalian cells with TurboID and split-TurboID. Nat Protoc. 2020;15:3971\u201399.","journal-title":"Nat Protoc"},{"key":"4017_CR43","doi-asserted-by":"publisher","first-page":"2171","DOI":"10.1038\/s41591-022-02007-7","volume":"28","author":"J Hallin","year":"2022","unstructured":"Hallin J, Bowcut V, Calinisan A, Briere DM, Hargis L, Engstrom LD, et al. Anti-tumor efficacy of a potent and selective non-covalent KRASG12D inhibitor. Nat Med. 2022;28:2171\u201382.","journal-title":"Nat Med"},{"key":"4017_CR44","doi-asserted-by":"publisher","first-page":"169162","DOI":"10.1016\/j.jmb.2025.169162","volume":"437","author":"HN Kim","year":"2025","unstructured":"Kim HN, Gasmi-Seabrook GMC, Uchida A, Gebregiworgis T, Marshall CB, Ikura M. Switch II pocket inhibitor allosterically freezes KRASG12D nucleotide-binding site and arrests the GTPase cycle. J Mol Biol. 2025;437:169162.","journal-title":"J Mol Biol"},{"key":"4017_CR45","doi-asserted-by":"publisher","first-page":"3862","DOI":"10.1038\/onc.2011.106","volume":"30","author":"G Fournier","year":"2011","unstructured":"Fournier G, Cabaud O, Josselin E, Chaix A, Ad\u00e9lade J, Isnardon D, et al. Loss of AF6\/afadin, a marker of poor outcome in breast cancer, induces cell migration, invasiveness and tumor growth. Oncogene. 2011;30:3862\u201374.","journal-title":"Oncogene"},{"key":"4017_CR46","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-015-1286-x","volume":"15","author":"T Yamamoto","year":"2015","unstructured":"Yamamoto T, Mori T, Sawada M, Matsushima H, Ito F, Akiyama M, et al. Loss of AF-6\/afadin induces cell invasion, suppresses the formation of glandular structures and might be a predictive marker of resistance to chemotherapy in endometrial cancer. BMC Cancer. 2015;15:275.","journal-title":"BMC Cancer"},{"key":"4017_CR47","doi-asserted-by":"publisher","DOI":"10.1186\/s12935-018-0662-4","volume":"18","author":"X Zhang","year":"2018","unstructured":"Zhang X, Wang H, Li Q, Li T. CLDN2 inhibits the metastasis of osteosarcoma cells via down-regulating the afadin\/ERK signaling pathway. Cancer Cell Int. 2018;18:160.","journal-title":"Cancer Cell Int"}],"container-title":["Oncogene"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41388-026-04017-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41388-026-04017-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41388-026-04017-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T15:06:26Z","timestamp":1793459186000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41388-026-04017-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,16]]},"references-count":47,"journal-issue":{"issue":"46","published-print":{"date-parts":[[2026,12,2]]}},"alternative-id":["4017"],"URL":"https:\/\/doi.org\/10.1038\/s41388-026-04017-y","relation":{},"ISSN":["0950-9232","1476-5594"],"issn-type":[{"value":"0950-9232","type":"print"},{"value":"1476-5594","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,16]]},"assertion":[{"value":"11 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 September 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 September 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 October 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All authors were employees and\/or shareholders of Novartis during their involvement related to this reported work.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"All methods were performed in accordance with relevant guidelines and regulations. No human participants or animals were involved in this study.","order":2,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Ethics"}}]}}